198 related articles for article (PubMed ID: 6630515)
1. Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.
Poh-Fitzpatrick MB; Sklar JA; Goldsman C; Lefkowitch JH
J Clin Invest; 1983 Oct; 72(4):1449-58. PubMed ID: 6630515
[TBL] [Abstract][Full Text] [Related]
2. Importance of bile acid structure in amelioration of griseofulvin-induced murine protoporphyric hepatopathy.
Berenson MM; Welch V; Garcia-Marin JJ
J Lab Clin Med; 1991 Jul; 118(1):89-98. PubMed ID: 2066649
[TBL] [Abstract][Full Text] [Related]
3. Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria.
Lefkowitch JH; Feng-Chen KC; Sklar JA; Poh-Fitzpatrick MB
Hepatology; 1983; 3(3):399-406. PubMed ID: 6840685
[TBL] [Abstract][Full Text] [Related]
4. [Experimental protoporphyria induced by griseofulvin. II. Effects of cholic acid ingestion in griseofulvin-induced protoporphyria mice].
Irifune H
Nihon Hifuka Gakkai Zasshi; 1988 Nov; 98(12):1177-82. PubMed ID: 3230643
[No Abstract] [Full Text] [Related]
5. [The influence of ursodesoxycholic acid (URSO) on griseofulvin (GF)-induced protoporphyria].
Irifune H; Tsukazaki N; Watanabe M; Nonaka S
Nihon Hifuka Gakkai Zasshi; 1991 Jul; 101(8):813-7. PubMed ID: 1942584
[TBL] [Abstract][Full Text] [Related]
6. [Reversibility of griseofulvin induced protoporphyria in the mice].
Irifune H
Nihon Hifuka Gakkai Zasshi; 1987 Jun; 97(7):801-4. PubMed ID: 3669397
[No Abstract] [Full Text] [Related]
7. Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions.
Poh-Fitzpatrick MB; Lamola AA
J Clin Invest; 1977 Aug; 60(2):380-9. PubMed ID: 874098
[TBL] [Abstract][Full Text] [Related]
8. Experimental murine protoporphyria induced by griseofulvin (GF): the relationship between hepatic porphyrin levels and liver function test values in mice treated with GF.
Tanaka K; Ohgami T; Nonaka S
J Dermatol; 1993 Sep; 20(9):545-53. PubMed ID: 8227709
[TBL] [Abstract][Full Text] [Related]
9. Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals.
Gschnait F; Konrad K; Hönigsmann H; Denk H; Wolff K
J Invest Dermatol; 1975 Sep; 65(3):290-9. PubMed ID: 1159316
[TBL] [Abstract][Full Text] [Related]
10. Bile secretion and liver microsomal mixed function oxidase system in mice with griseofulvin-induced hepatic protoporphyria.
Cantoni L; Di Padova C; Rovagnati P; Ruggieri R; Dal Fiume D; Tritapepe R
Toxicology; 1983 May; 27(1):27-39. PubMed ID: 6679936
[TBL] [Abstract][Full Text] [Related]
11. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding.
McCullough AJ; Barron D; Mullen KD; Petrelli M; Park MC; Mukhtar H; Bickers DR
Gastroenterology; 1988 Jan; 94(1):177-81. PubMed ID: 3335288
[TBL] [Abstract][Full Text] [Related]
12. The synergistic effect of chlorinated chemicals and low concentration of griseofulvin on porphyrin metabolism--the effect of 0.05% hexachlorobenzene and 0.1% griseofulvin on young and old mice.
Tsukazaki N; Nonaka S; Ohgami T
Fukuoka Igaku Zasshi; 1993 May; 84(5):217-21. PubMed ID: 8330839
[TBL] [Abstract][Full Text] [Related]
13. Griseofulvin causing hyperhemopexinemia and hepatic proliferation in mice: an in vivo and in vitro study.
Cripps DJ; Liem HH; Muller-Eberhard U
J Invest Dermatol; 1977 Feb; 68(2):82-7. PubMed ID: 833440
[TBL] [Abstract][Full Text] [Related]
14. Griseofulvin-induced protoporphyria revisited.
Gederaas OA; Brekke OL; Romslo I
Photodermatol Photoimmunol Photomed; 1990 Apr; 7(2):82-5. PubMed ID: 2400679
[TBL] [Abstract][Full Text] [Related]
15. Evidence that hepatic crystalline deposits in a patient with protoporphyria are composed of protoporphyrin.
Bloomer JR; Enriquez R
Gastroenterology; 1982 Mar; 82(3):569-73. PubMed ID: 7054049
[TBL] [Abstract][Full Text] [Related]
16. Hepatic protoporphyrin production in human protoporphyria. Effects of intravenous hematin and analysis of erythrocyte protoporphyrin distribution.
Lamon JM; Poh-Fitzpatrick MB; Lamola AA
Gastroenterology; 1980 Jul; 79(1):115-25. PubMed ID: 7380207
[TBL] [Abstract][Full Text] [Related]
17. Effect of ursodeoxycholic acid on experimental hepatic porphyria induced by griseofulvin.
Choi SW; Han JH; Lim KT; Cho HM; Chung KW; Sun HS; Park DH; Kim BS; Seo EJ
J Korean Med Sci; 1991 Jun; 6(2):146-56. PubMed ID: 1751019
[TBL] [Abstract][Full Text] [Related]
18. Chenodeoxycholic acid therapy in erythrohepatic protoporphyria.
Van Hattum J; Baart de la Faille H; Van den Berg JW; Edixhoven-Bosdijk A; Wilson JH
J Hepatol; 1986; 3(3):407-12. PubMed ID: 3559148
[TBL] [Abstract][Full Text] [Related]
19. Effect of decreased ferrochelatase activity on iron and porphyrin content in mitochondria of mice with porphyria induced by griseofulvin.
Tangerås A
Biochim Biophys Acta; 1986 Jun; 882(1):77-84. PubMed ID: 3707999
[TBL] [Abstract][Full Text] [Related]
20. Changes in protoporphyrin distribution dynamics during liver failure and recovery in a patient with protoporphyria and Epstein-Barr viral hepatitis.
Poh-Fitzpatrick MB; Whitlock RT; Leftkowitch JH
Am J Med; 1986 May; 80(5):943-50. PubMed ID: 3010717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
